PTPRO and familial pancreatic carcinoma: On the other hand, the expression of PTPRO indicated a weak correlation with CD4+ T cells (r = 0.031, P = 6.84e-01) and B cells (r = 0.025, P = 7.45e-01) in pancreatic cancers.